GSK Consumer (SKB) posted 12.3% YoY sales growth (including operating income) to INR11.1b (in-line). EBITDA grew 38% YoY to INR2.3b (our estimate: INR2.2b). Reported PAT rose 51.6% YoY to INR2b, led by a steep 75% YoY rise...